The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient’s Experience
Thoughts
Head empty
Annotations
zafar2013 - p. 382
ligible participants were patients with solid tumors actively receiving chemotherapy or hormonal therapy
zafar2013 - p. 382
exploratory, observational study of self-reported, treatment-related costs (objective financial burden) and patient-reported subjective financial burden among patients with cancer seeking copayment assistance
zafar2013 - p. 382
Beginning 1 month after the baseline survey, participants completed monthly cost diaries for up to 4 months. Initially, the study included four weekly cost diaries for the first month, followed by three monthly diaries.
zafar2013 - p. 383
Logistic regression was used to assess the relationship between sociodemographics and subjective financial burden.
zafar2013 - p. 383
Variables were selected for inclusion in multivariate models using a combination of the statistical selection criterion of p .25 in unadjusted analyses and clinical relevance
Note: Red flag
zafar2013 - p. 385
This suggests that measuring out-of-pocket expenses as a proportion of income might not be sufficient to capture objective financial burden, and some subjective assessment should also be considered to identify patients who may benefit from intervention
Note: This occurred maybe because perception is a core moderating variable
zafar2013 - p. 388
Our subjective measure of financial burden was not validated.